Search the collection

4 results for Phosphodiesterase+type+9+inhibitor

Sort by:

Sort by

Limit results to:

20 per page

4 results for Phosphodiesterase+type+9+inhibitor

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodrom...
Author / Creator:Frölich, Lutz ; Wunderlich, Glen ; Thamer, Claus ; Roehrle, Michael ; Garcia, Jr, Miguel ; Dubois, Bruno
Publisher:England: BioMed Central Ltd
Journal title:Alzheimer's research & therapy, 2019-02, Vol.11 (1), p.18-18, Article 18
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ReportsFull Text
Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodrom...
Author / Creator:Frolich, Lutz ; Wunderlich, Glen ; Thamer, Claus ; Roehrle, Michael ; Garcia, Miguel ; Dubois, Bruno
Publisher:BioMed Central Ltd
Journal title:Alzheimer's Research & Therapy, 2019, Vol.11 (1)
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
Newsletter articlesFull Text
Neurodegenerative Diseases and Conditions - Alzheimer Disease; Researchers from Boehringer Ingelheim Detail New Studies and Findings in the Area of Alzheimer Disease (Evaluation of the efficacy, safet...
Publisher:Atlanta: NewsRx
Journal title:Veterinary Week, 2020, p.101
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
Newsletter articlesFull Text
Researchers from Boehringer Ingelheim Detail New Studies and Findings in the Area of Alzheimer Disease (Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel ph...
Publisher:NewsRX LLC
Journal title:Biotech Week, 2020, p.101
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Search the collection

Export record to excel

Export this record

Export record to excel

Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodrom...

Export this record

Export record to excel

Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodrom...

Export this record

Export record to excel

Neurodegenerative Diseases and Conditions - Alzheimer Disease; Researchers from Boehringer Ingelheim Detail New Studies and Findings in the Area of Alzheimer Disease (Evaluation of the efficacy, safet...

Export this record

Export record to excel

Researchers from Boehringer Ingelheim Detail New Studies and Findings in the Area of Alzheimer Disease (Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel ph...

Refine your search